Post-Conference Report
This report provides a complete guide to all the checkpoint-relevant abstracts presented at the 2023 ESMO Congress, offering you a concise summary of each abstract as well as additional analysis.
Beacon customers, please log in to Beacon and go to the ‘Analysis’ tab to download the full version.
Related content
ASCO 2024: Checkpoint Highlights
Investment Trends in Early-Stage Biopharma: A Beacon Data Perspective
Webinar – Harnessing STING & TLR: Current Developments, Clinical Trials, and Key Players in the Landscape
Find out more
Beacon is the essential decision-support tool for developers of complex therapeutics. Our market-defining, proprietary ontologies, combined with the most accurate and comprehensive life sciences data, provide our customers with unparalleled visibility of the drug and trial landscape.
With Beacon, you can make drug development decisions with confidence. This is why 23 of the world’s top 25 drug developers trust us.
Speak with our Team
Our dedicated account and research teams can help you with questions by showing you how this insight and data is collated on Beacon.
